Orenitram (Treprostinil)
Orenitram (Treprostinil)
- Medicine Name: Orenitram
- API: Treprostinil
- Dosage Form & Strength: Extended-Release Tablets: 0.125 mg, 0.25 mg, 1 mg, 2.5 mg and 5 mg
- Manufactured By: United Therapeutics
Orenitram (treprostinil) is a prostacyclin mimetic used for the treatment of pulmonary arterial hypertension (PAH) which is high blood pressure in the arteries of the lungs. Orenitram can help slow down the progression of disease and improve the ability to exercise. It is not known if this medicine is safe and promising in children.
Recommended Dosage: The recommended initial dose is 0.125 mg three times daily with food, taken approximately 8 hours apart, or 0.25 mg twice daily with food, taken approximately 12 hours apart. Swallow tablets whole; without crushing, splitting, or chewing. Titrate by 0.125 mg three times daily or 0.25 or 0.5 mg twice daily not more frequently than every 3-4 days. Increase the dose to the highest tolerated dose. In case the dose increments are not tolerated, consider titrating slower. If intolerable pharmacologic effects occur, decrease the dose in increments of 0.125 mg three times daily or 0.25 mg twice daily.
- Abrupt discontinuation or sudden large reductions in dosage of Orenitram extended-release tablets may result in worsening of pulmonary arterial hypertension (PAH) signs and symptoms.
- The Orenitram tablet shell does not dissolve. In patients with diverticulosis, tablets of Orenitram can lodge in a diverticulum.
- Patients should let their healthcare provider know if they are pregnant, breastfeeding, or plan to become pregnant or breastfeed. It is unknown if Orenitram will harm their unborn baby or if the medicine passes into their breast milk. They should talk to their healthcare provider about the best way to feed their baby during treatment.
- Patients should inform their doctor about all the medicines they take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Orenitram and other medicines may affect each other causing side effects. Never start any new medicine until you check with your doctor. Especially patients should tell their doctor if they take another drug that contains treprostinil, such as Remodulin or Tyvaso.
What documents are required to import ORENITRAM to India?
ORENITRAM (treprostinil) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor
- Patients diagnostic reports
- Patients ID proof (issued by the government of India)
How does the order be confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from Doctor
- Import permit if applicable
Is ORENITRAM available in India?
ORENITRAM (treprostinil tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Orenitram in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.ORENITRAM can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
(Indian Pharma Network) can facilitate the supply of ORENITRAM (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Orenitram tablet price in India.
We take guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source the ORENITRAM (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network (IPN) is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Orenitram®?
Treprostinil is a Generic Name for the trade name drug Orenitram®.
What is the Manufacturer’s Name of Orenitram®?
Orenitram® is manufactured by United Therapeutics Corp.
Is Orenitram® approved by the FDA?
Yes, Orenitram® is approved by the FDA. Date of first approval: December 20, 2013.
What is the dosage and form of Orenitram® supplied?
Orenitram® is supplied as extended-release tablets: 0.125 mg, 0.25 mg, 1 mg, 2.5 mg, and 5 mg for oral administration.
What are the most common side effects of Orenitram®?
The most common side effects of Orenitram® are headache, vomiting, diarrhea, nausea, jaw pain, and flushing.
How much does Orenitram® cost in India?
The cost of Orenitram in India can vary. To procure this prostacyclin mimetic legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Orenitram®?
Store the extended-release tablets at 20 to 25°C (68 to 77°F) with excursions permitted to 15 to 30°C (59 to 86°F). Keep out of reach of children.
Is it safe to buy Orenitram® online in India?
Yes, one can buy Orenitram online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can facilitate the supply of Orenitram® through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.